Refine your search
Collections
Co-Authors
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Tyagi, Shivani
- Prevalence and Antibiotic Resistance Pattern of Staphylococcus aureus isolates from Clinical samples at a Tertiary Care Hospital, North India
Abstract Views :261 |
PDF Views:112
Authors
Affiliations
1 Department of Microbiology, Dr. Baba Saheb Ambedkar Medical College & Hospital, New Delhi − 110085, IN
2 Department of Microbiology, Christian Medical College & Hospital, Ludhiana, Punjab − 141008, IN
1 Department of Microbiology, Dr. Baba Saheb Ambedkar Medical College & Hospital, New Delhi − 110085, IN
2 Department of Microbiology, Christian Medical College & Hospital, Ludhiana, Punjab − 141008, IN
Source
International Journal of Medical and Dental Sciences, Vol 10, No 1 (2021), Pagination: 1919-1924Abstract
Background: Staphylococcus aureus (S. aureus) is a well recognized nosocomial and community acquired pathogen which is implicated in causing a wide spectrum of superficial, deep pyogenic infections and toxin mediated illnesses. Localized infections sometimes progress to systemic infections, while ‘spontaneous’ bacteraemia also occur without an evident septic focus, particularly in chronic debilitated immunocompromised patients. Emergence of drug resistance to penicillins and penicillinase-resistant penicillins (i.e., oxacillin and methicillin) is a globally recognized problem. Methicillin Resistant Staphylococcus aureus isolates are also important with respect to the range of nosocomial infections it causes, leading to an increase in the hospital expenditure and mortality or morbidity rate. The increased prevalence of such resistant strains has narrowed down the list of available therapeutic options. Therefore, information regarding the prevalence of S. aureus infections in a health care setting and determining its current antibiotic resistance profile becomes crucial in selecting appropriate treatment regime. Therefore, the current study was done in the department of Microbiology to determine the prevalence of S. aureus infections and the antibiotic resistance pattern of S. aureus isolates from various clinical specimens at our tertiary care hospital in North India. Materials and Methods: A one year prospective study was carried out in the Department of Microbiology, at a tertiary care hospital in North India where non-duplicate strains of S. aureus isolated from various clinical specimens received in the Microbiology laboratory were studied. All S. aureus isolates were subjected to Antibiotic Susceptibility Testing using Kirby Bauer’s disk diffusion method on Mueller Hinton Agar plates in accordance to CLSI guidelines. The antibiotics tested included Penicillin (10U), Amoxicillin-clavulanic acid (20/10μg), Sulphamethoxazole-trimethoprim (1.25/23.75μg), Ciprofloxacin (5μg), Erythromycin (15μg), Clindamycin (2μg), Vancomycin (30μg), Teicoplanin (30μg) and Linezolid (30μg). Results: A total of 23,699 clinical specimens were processed in the laboratory while conducting this study, from which 1233 clinical isolates of S. aureus were identified and processed further. Among all clinical specimens, pyogenic samples (63.1%) yielded maximum number of S. aureus strains followed by blood samples (29.9%) and urine samples (4.8%). S. aureus infection was more evident in hospitalized 71.2% patients than in OPD patients 28.8%. Seasonal variation was also seen in isolation of S. aureus, with a higher percentage of isolates obtained during summer season than during winter season. On antibiotic susceptibility testing, 49.6% strains were Methicillin Resistant. Majority of the isolates were found resistant to Penicillin (92.1%), followed by Erythromycin (59%). Almost half of the total isolates were resistant to Sulphamethoxazole-Trimethoprim (49.3%) followed by Amoxicillin- Clavulanic acid (47.8%), Ciprofloxacin (43.4%) and Clindamycin (18.4%). Antibiotics to which all isolates showed 100% susceptibility included Vancomycin, Teicoplanin, Linezolid. Conclusion: Given the high prevalence of resistance to antibiotics seen in this study, effective treatment of infections caused by multidrug resistant Staphylococcal strains may become challenging. Drugs like Vancomycin, Teicoplanin and Linezolid promise to work as miracle drugs against the multidrug resistant MRSA strains but we need to warrant judicious use of these wonder drugs to conserve them for future use.Keywords
Antibiotic Susceptibility Testing, Antimicrobial Resistance, Methicillin Resistant Staphylococcus aureus (MRSA), Staphylococoous aureus.References
- Yilmaz G, Aydin K, Iskender S, Caylan R, Koksal I. Detection and prevalence of inducible clindamycin resistance in staphylococci. J. Med. Microbiol. 2007; 56:342-345. https://doi.org/10.1099/jmm.0.46761-0. PMid: 17314364.
- Baird D. Staphylococcus: Cluster Forming Gram-Positive Cocci. In: Collee JG, Fraser AG, Marmion BP, Simmons A, editors. Mackie & McCartney Practical Medical Microbiology, 14th ed. Chichester: Churchil Livingstone; 2012. p.245-258.
- Gram-positive Cocci: Part-I: Staphylococci and Related Gram-Positive Cocci. In: Winn WC, Allen SD, Janda WM, Koneman EW, Procop GW, Schreckenberger PC, et al, editors. Koneman’s Color Atlas and Textbook of Diagnostic Microbiology, 6th ed. USA: Lippincott Williams and Wilkins; 2006. p.624-661.
- Al-Zoubi MS, Al-Tayyar IA, Hussein E, Al Jabali A, Khudairat S. Antimicrobial susceptibility pattern of Staphylococcus aureus isolated from clinical specimens in Northern area of Jordan. Iran. J. Microbiol. 2015; 7:265-272.
- Specimen Management. In: Bailey & Scott’s Diagnostic Microbiology. 13th ed. Mosby, USA; 2014. p.53-67.
- CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty Third Informational Supplement. CLSI Document M100-S23. Wayne, PA: Clinical and Laboratory Standards Institute; 2013.
- Gurung RR, Maharjan P, Chhetri GG. Antibiotic resistance pattern of Staphylococcus aureus with reference to MRSA isolates from pediatric patients. Future Sci. OA. 2020; 6(4):FSO464. https://doi.org/10.2144/fsoa-2019-0122. PMid: 32257376, PMCid: PMC7117559.
- Mukhiya R, Shrestha A, Rai S, Panta K, Singh R, Rai G, et al. Prevalence of Methicillin-Resistant Staphylococcus aureus in Hospitals of Kathmandu Valley. NJST [Internet]. 10 Mar 2013; 13(2):185-190. Cited on 17th Jul 2020. https://doi.org/10.3126/njst.v13i2.7734.
- Pandey S, Raza M, Bhatta C. Prevalence and antibiotic sensitivity pattern of Methicillin- Resistant- Staphylococcus aureus in Kathmandu Medical College - Teaching Hospital. JIOM Nepal. 20th May 2019; 34(1):13-17. Cited on 17th Jul 2020. https://doi.org/10.3126/joim.v34i1.9117.
- Chen AE, Goldstein M, Carroll K, Song X, Perl TM, Siberry GK. Evolving epidemiology of pediatric Staphylococcus aureus cutaneous infections in a Baltimore hospital. Pediatr. Emerg. Care. 2006; 22:717-723. https://doi.org/10.1097/01.pec.0000236832.23947.a0. PMid: 17047471.
- Kakar N, Kumar V, Mehta G, Sharma RC, Koranne RV. Clinico‐bacteriological study of pyodermas in children. J. Dermatol. 1999; 26:288-293. https://doi.org/10.1111/j.1346-8138.1999.tb03474.x. PMid: 10380429.
- Morrison‐Rodriguez SM, Pacha LA, Patrick JE, Jordan NN. Community‐associated methicillin‐resistant Staphylococcus aureus infections at an army training installation. Epidemiol. Infect. 2010; 138:721-729. https://doi.org/10.1017/S0950268810000142. PMid: 20096150.
- Rogers M, Dorman DC, Gapes M, Ly J. A three‐year study of impetigo in Sydney. Med. J. Aust. 1987; 147:6365. https://doi.org/10.5694/j.1326-5377.1987.tb133260.x. PMid: 3299015.
- Szczesiul JM, Shermock KM, Murtaza UI, Siberry GK. No decrease in clindamycin susceptibility despite increased use of clindamycin for pediatric community‐associated methicillin‐resistant Staphylococcus aureus skin infections. Pediatr. Infect. Dis. J. 2007; 26:852-854. https://doi.org/10.1097/INF.0b013e318124aa5c. PMid: 17721387.
- McBride ME, Duncan WC, Knox JM. The environment and the microbial ecology of human skin. Appl. Environ. Microbiol. 1977; 33:603-608. https://doi.org/10.1128/ AEM.33.3.603-608.1977. PMid: 16345214, PMCid: PMC170732.
- Deotale V, Mendiratta DK, Raut U, Narang P. Inducible clindamycin resistance in Staphylococcus aureus isolated from clinical samples. Indian J. Med. Microbiol. 2010; 28:124-126. https://doi.org/10.4103/0255-0857.62488. PMid: 20404457.
- Gadepalli R, Dhawan B, Mohanty S, Kapil A, Das BK, Chaudhry R. Inducible clindamycin resistance in clinical isolates of Staphylococcus aureus. Indian J. Med. Res. 2006; 123:571-573.
- Azap OK, Arslan H, Timurkaynak F, Yapar G, Oruc E, Gagir U. Incidence of inducible clindamycin resistance in staphylococci: First results from Turkey. Clin. Microbiol. Infect. 2005; 11:582-584. https://doi.org/10.1111/j.14690691.2005.01174.x. PMid: 15966979.
- Velvizhi G, Sucilathangam G, Palaniappan N. Prevalence and phenotypic detection of erythromycin induced Resistance to clindamycin in MRSA isolates. J. Clin. Diagn. Res. 2011; 5:1195-1198.
- Fasih N, Irfan S, Zafar A, Khan E, Hasan R. Inducible clindamycin resistance due to expression of erm genes in Staphylococcus aureus: Report from a tertiary care Hospital Karachi, Pakistan. J. Pak. Med. Assoc. 2010; 60:750-753.
- Prabhu K, Rao S, Rao V. Inducible clindamycin resistance in Staphylococcus aureus isolated from clinical samples. J. Lab Physicians. 2011; 3:25-27. https://doi.org/10.4103/09742727.78558. PMid:21701659 PMCid:PMC3118052
- Angel MR, Balaji V, Prakash JAJ, Brahmadathan KN, Mathews MS. Prevalence of inducible clindamycin resistance in gram positive organisms in a tertiary care centre. Indian J. Med. Microbiol. 2008; 26:262-264. https://doi.org/10.4103/0255-0857.42041. PMid: 18695329.
- Mittal V, Kishore S, Siddique ME. Prevalence of inducible clindamycin resistance among clinical isolates of Staphylococcus aureus detected by phenotypic method: A preliminary report. J. Infect. Dis. Immun. 2013; 5:10-12. https://doi.org/10.5897/JIDI12.005.
- Reddy PS, Suresh R. Phenotypic detection of Inducible Clindamycin resistance among the clinical isolates of Staphylococcus aureus by using the lower limit of inter disk space. J. Microbiol. Biotech. Res. 2012; 2:258-264.
- Mycological Profile and Prevalence of Superficial Mycoses Agents: A Study from North India
Abstract Views :218 |
PDF Views:120
Authors
Affiliations
1 Department of Microbiology, Dr. Baba Saheb Ambedkar Medical College and Hospital, New Delhi–110085, IN
2 Director Professor & Head, Department of Microbiology, Lady Hardinge Medical College and Associated Hospitals, Connaught Place, New Delhi–110001, IN
3 Department of Microbiology, Lady Hardinge Medical College & Associated Hospitals, Connaught Place, New Delhi–110001, IN
1 Department of Microbiology, Dr. Baba Saheb Ambedkar Medical College and Hospital, New Delhi–110085, IN
2 Director Professor & Head, Department of Microbiology, Lady Hardinge Medical College and Associated Hospitals, Connaught Place, New Delhi–110001, IN
3 Department of Microbiology, Lady Hardinge Medical College & Associated Hospitals, Connaught Place, New Delhi–110001, IN
Source
International Journal of Medical and Dental Sciences, Vol 10, No 1 (2021), Pagination: 1925-1931Abstract
Background: Superficial fungal infections are one of the commonest human infections. Causative agents of such infections may vary from yeasts like Candida species, Trichosporon species to dermatophytes and non-dermatophyte moulds. Fungal culture therefore, holds importance in identification and characterization of a fungal isolate, so that proper diagnosis can be made and correct treatment is instituted. Our objective was to study the etiology of the superficial fungal infections in patients presenting to the dermatology department in a tertiary care hospital in New Delhi. Materials and Methods: A total of 340 skin and hair samples from patients clinically suspected to have superficial fungal infection of skin and hair were microscopically examined and cultured over a period of 2 years. The percentage and frequency distribution of etiological fungal agents was studied. Also the performance of the culture and microscopy as methods of detecting fungal agents was statistically compared using Kappa and proportions of positive and negative agreement as well as McNemar’s Chi-squared value. Corresponding p-values were also calculated for both kappa and Chi-squared values. The analysis has been done using Epitools. Results: Of these, 57.6% were positive for fungal elements by microscopic examination and the overall positivity of fungal infection was 70%. Out of 238 culture positive samples, 72.7% grew dermatophytes and 27.3% grew non-dermatophytes (including 16.8% yeasts and 10.9% non-dermatophyte moulds. Trichophyton mentagrophytes was the commonest (60.7%) dermatophyte isolated, followed by T. rubrum (17.3%), T. violaceum (7.5%), T. tonsurans (7.5%), T. verucosum (2.9%), Microsporum gypseum (1.2%) and M. canis (0.6%). Among the isolated non-dermatophytes, Candida species was the commonest (50.8%) majority of which were C. albicans, other non-dermatophytes included moulds like Fusarium spp. (6.1%), Aspergillus fumigatus (4.6%), A. flavus (3.1%), Alternaria spp. (3.1%), Acremonium spp. (3.1%), A. niger (3.1%) etc. and yeasts like Trichosporon spp. (10.8%). Conclusion: Dermatophytosis still remains the most common type of fungal infection involving skin and its appendages but non-dermatophytes are also slowly emerging as the causative agents for these infections.Keywords
Dermatophytes, Hair, Skin, Superficial Mycoses, Yeast.References
- Brown GD, Denning DW, Gow NAR, Levitz SM, Netea MG, White TC. Hidden killers: Human fungal infections. Sci. Transl. Med. 2012; 4: 165rv13. https://doi.org/10.1126/ scitranslmed.3004404
- Mishra M, Mishra S, Singh PC, Mishra BC. Clinicomycological profile of superficial mycoses. Indian J.
- Dermatol. Venereol. Leprol. 1998; 64: 283–285.
- Peerapur BV, Inamdar AC, Pushpa PV, Srikant B. Clinicomycological study of Dermatophytosis in Bijapur. Ind. J. Med. Microbiol. 2004; 22: 273–274.
- Yehia MA, El-Ammawi TS, Al-Mazidi KM, Abu El-Ela MA, Al-Ajmi HS. The spectrum of fungal infections with a special reference to dermatophytoses in the capital area of Kuwait during 2000-2005: A retrospective analysis. Mycopathologia. 2010; 169: 241–246. https://doi.org/10.1007/s11046-009-9252-2
- Grover WCS, Roy CP. Clinico-mycological profile of superficial mycosis in a hospital in north east India. Med. J. Armed Forces India. 2003; 59: 114–116. https://doi.org/10.1016/S0377-1237(03)80053-9
- Chander J. Dermatophytoses. In: Textbook Of Medical Mycology, Chander J (ed). Mehta Publishers, Pune, 2009: pp. 91-100 & 376–388.
- Havlickova, B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses. 2008; 51: 2–15. https://doi.org/10.1111/j.1439-0507.2008.01606.x
- Brasch, J. Pathogenesis of tinea. J Dtsch Dermatol Ges. 2010; 8: 780–786. https://doi.org/10.1111/j.16100387.2010.07481.x
- Bassiri-Jahromi S, Khaksari AA. Epidemiological survey of dermatophytosis in Tehran, Iran, from 2000 to 2005. Indian J. Dermatol. Venereol. Leprol. 2009; 75: 142–147. https:// doi.org/10.4103/0378-6323.48658
- Anupama, A. Isolation and Identification of Dermatophytes from Clinical Samples – One Year Study. Int. J. Curr. Microbiol. App. Sci. 2017; 6: 1276–1281. https://doi.org/10.20546/ijcmas.2017.611.152
- Vasudha CL, Anuradha B, Faizan MMA. A Study on Prevalence and Clinico-Mycological Profile of Superficial Fungal Infections in a Tertiary Care Hospital. Int. J. Curr. Microbiol. App. Sci. 2019; 8: 2553–2563. https://doi.org/10.20546/ijcmas.2019.801.268
- Kaur R. Clinico-Mycological Pattern of Hair and Skin Infection in New Delhi. J. Intensive & Crit. Care. 2017; 3: 2. https://doi.org/10.21767/2471-8505.100074
- Venkatesan G, Ranjit Singh AJA, Murugesan AG, Janaki C, Gokul Shankar S. Trichophyton rubrum-the predominant etiological agent in human dermatophytosis in Chennai, India. Afr. J. Microbiol. Res. 2007; 1: 9–12.
- Lyngdoh CJ, Lyngdoh WV, Choudhury B, Sangma KA, Bora I, Khyriem AB. “Clinico-mycological profile of dermatophytosis in Meghalaya”. Int. J. Med. Public Health. 2013; 3: 254–256. https://doi.org/10.4103/2230-8598.123442
- Kalita JM, Sharma A, Bhardwaj A, Nag VL. Dermatophytoses and spectrum of dermatophytes in patients attending a teaching hospital in Western Rajasthan, India. J. Family Med. Prim. Care. 2019; 8: 1418–1421. https://doi.org/10.4103/jfmpc.jfmpc_159_19
- Kumar S, Mallya PS, Kumari P. “Clinico-mycological study of dermatophytosis in a tertiary care hospital”. Int. J. Sci. Study. 2014; 1: 27–32.
- Bose S, Barapatre R. Clinico--mycological profiles of dermatophytoses in a tertiary care rural hospital. Int. J. of Biomed. Adv. Res. 2013; 4 (1): 31–34. https://doi.org/10.7439/ijbar.v4i1.900
- Abu-Elteen KH, Abdul M. Prevalence of dermatophytoses in the Zarqa district of Jordan. Mycopathologia. 1999; 145: 137–142. https://doi.org/10.1023/A:1007009218316
- Bindu V, Pavithran K. Clinico - mycological study of dermatophytosis in Calicut. Indian J. Dermatol. Venereol. Leprol. 2002; 68: 259-261.
- Bhatia VK, Sharma PC. Epidemiological studies on Dermatophytosis in human patients in Himachal Pradesh, India. SpringerPlus. 2014; 3: 134. https://doi.org/10.1186/2193-1801-3-134
- Khadka S, Sherchand JB, Pokharel DB, et al. Clinicomycological Characterization of Superficial Mycoses from a Tertiary Care Hospital in Nepal. Dermatol. Res. Pract. 2016; 2016: 9509705. https://doi.
- org/10.1155/2016/9509705
- Pakshir K, Bahaedinie L, Rezaei Z, et al. In Vitro activity of six antifungal drugs against clinically important dermatophytes. Jundishapur J. Microbiol. 2009; 2: 158–163.
- Dulla S, Kumari PS, Kumari PL. Prevalence of Nondermatophytes in Clinically Diagnosed Tineasis. Int. J. Curr. Microbiol. App. Sci. 2015; 4: 541–549.
- Lakshmanan A, Ganesh KP, Raam MS, Hemamalini M, Madhavan R. Epidemiological and clinical pattern of dermatomycoses in rural India. Indian J. Med. Microbiol. 2015; 33: 134–136. https://doi.org/10.4103/0255-0857.150922